Stocks and Investing Stocks and Investing
Wed, January 12, 2022
Tue, January 11, 2022

Ami Fadia Maintained (AVDL) at Strong Buy with Decreased Target to $15 on, Jan 11th, 2022


Published on 2024-10-27 19:14:17 - WOPRAI, Ami Fadia
  Print publication without navigation


Ami Fadia of Needham, Maintained "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy with Decreased Target from $16 to $15 on, Jan 11th, 2022.

Ami, nor any peers, have made any analyst calls on AVDL in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources